Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040217986> ?p ?o ?g. }
- W2040217986 endingPage "55" @default.
- W2040217986 startingPage "47" @default.
- W2040217986 abstract "Recently, a variety of HPV-related proteins have been synthesized and their utility as diagnostic and prognostic markers in cervical cancers needs to be assessed. The ability to generate preparative amounts of HPV-16 L1/L2 VLPs and E6, E7 proteins may have implications for the development of a serologic assay to detect anti-HPV-16 virion immune responses. The purpose of the study is to improve the way of proper management of the cervical cancer by investigating the utility of the recently developed HPV-16 L1/L2 VLPs, HPV-16 E6, E7 proteins as the clinical serologic markers through antibody reactions by comparison with those of SCCA and CEA which have been used as tumor markers for cervical cancer.The serologic responses in Korean women with cervical neoplasia by ELISA using HPV-16 L1/L2 VLPs and radioimmunoprecipitation assay (RIPA) using in vitro translated HPV-16 E6, E7 proteins were investigated. PCR using E6 type-specific primers for HPV-16/18 was used to determine the presence and type of HPV infection (normal controls, 15 cases; preinvasive lesions, 28 cases; invasive cervical cancers, 124 cases).The sera of 34% (42/124) of cervical cancers were positive for SCCA and the sera of 18% (22/124) of cervical cancers were positive for CEA. The positivity of SCCA was increased with advancing clinical stages, but the antibody levels were not correlated with clinical stage of disease. The sera of 7% (1/15) of normal controls, 39% (11/28) of preinvasive lesions, and 56% (70/124) of patients with cervical cancer were ELISA positive for HPV-16 L1/L2 VLPs (P < 0.05). The sera of 7% (2/28) of preinvasive lesions and 51% (63/124) of cervical cancers were positive for in vitro translated HPV-16 E6 protein (P < 0.05) and the sera of 11% (3/28) of preinvasive lesions and 33% (41/124) of cervical cancers were positive for in vitro translated HPV-16 E7 protein (P < 0.05). The antibody levels to HPV-16 E7 protein were correlated to clinical stage and tumor burden in a significant number of cervical cancers.These data suggest that a considerable number of patients with cervical neoplasia generated positive antibody response to L1/L2 VLPs and in vitro translated E6, E7 proteins of HPV-16. These HPV-16-associated proteins might be disease-specific markers which could be useful in an adjunctive diagnostic assay and a seroepidemiologic study of HPV-related cervical neoplasia. In particular, the monitoring of antibody to HPV-16 E7 protein seems to be valuable in the proper management of cervical cancers for specific tumor markers." @default.
- W2040217986 created "2016-06-24" @default.
- W2040217986 creator A5035792424 @default.
- W2040217986 creator A5063335685 @default.
- W2040217986 creator A5073480785 @default.
- W2040217986 creator A5079102875 @default.
- W2040217986 creator A5083074248 @default.
- W2040217986 creator A5083655525 @default.
- W2040217986 creator A5087950508 @default.
- W2040217986 creator A5088178791 @default.
- W2040217986 date "1998-04-01" @default.
- W2040217986 modified "2023-09-25" @default.
- W2040217986 title "HPV-16-Related Proteins as the Serologic Markers in Cervical Neoplasia" @default.
- W2040217986 cites W1482765475 @default.
- W2040217986 cites W1660768030 @default.
- W2040217986 cites W1767781328 @default.
- W2040217986 cites W1807715620 @default.
- W2040217986 cites W1973493246 @default.
- W2040217986 cites W1975207281 @default.
- W2040217986 cites W1992067510 @default.
- W2040217986 cites W1993520079 @default.
- W2040217986 cites W1997521650 @default.
- W2040217986 cites W1998995312 @default.
- W2040217986 cites W2000857492 @default.
- W2040217986 cites W2010560157 @default.
- W2040217986 cites W2013958167 @default.
- W2040217986 cites W2025762172 @default.
- W2040217986 cites W2029810609 @default.
- W2040217986 cites W2033052965 @default.
- W2040217986 cites W2033997219 @default.
- W2040217986 cites W2038500217 @default.
- W2040217986 cites W2046041844 @default.
- W2040217986 cites W2056993860 @default.
- W2040217986 cites W2059143396 @default.
- W2040217986 cites W2059898309 @default.
- W2040217986 cites W2060786724 @default.
- W2040217986 cites W2086444144 @default.
- W2040217986 cites W2094773344 @default.
- W2040217986 cites W2107904085 @default.
- W2040217986 cites W2109347835 @default.
- W2040217986 cites W2152959169 @default.
- W2040217986 cites W2165877898 @default.
- W2040217986 cites W2335526956 @default.
- W2040217986 cites W3128343078 @default.
- W2040217986 cites W4361868650 @default.
- W2040217986 doi "https://doi.org/10.1006/gyno.1998.4963" @default.
- W2040217986 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9570998" @default.
- W2040217986 hasPublicationYear "1998" @default.
- W2040217986 type Work @default.
- W2040217986 sameAs 2040217986 @default.
- W2040217986 citedByCount "32" @default.
- W2040217986 countsByYear W20402179862013 @default.
- W2040217986 countsByYear W20402179862014 @default.
- W2040217986 countsByYear W20402179862016 @default.
- W2040217986 countsByYear W20402179862018 @default.
- W2040217986 countsByYear W20402179862019 @default.
- W2040217986 countsByYear W20402179862020 @default.
- W2040217986 countsByYear W20402179862021 @default.
- W2040217986 countsByYear W20402179862022 @default.
- W2040217986 crossrefType "journal-article" @default.
- W2040217986 hasAuthorship W2040217986A5035792424 @default.
- W2040217986 hasAuthorship W2040217986A5063335685 @default.
- W2040217986 hasAuthorship W2040217986A5073480785 @default.
- W2040217986 hasAuthorship W2040217986A5079102875 @default.
- W2040217986 hasAuthorship W2040217986A5083074248 @default.
- W2040217986 hasAuthorship W2040217986A5083655525 @default.
- W2040217986 hasAuthorship W2040217986A5087950508 @default.
- W2040217986 hasAuthorship W2040217986A5088178791 @default.
- W2040217986 hasConcept C121608353 @default.
- W2040217986 hasConcept C126322002 @default.
- W2040217986 hasConcept C142724271 @default.
- W2040217986 hasConcept C143998085 @default.
- W2040217986 hasConcept C159654299 @default.
- W2040217986 hasConcept C203014093 @default.
- W2040217986 hasConcept C2778220009 @default.
- W2040217986 hasConcept C2778580637 @default.
- W2040217986 hasConcept C2779134260 @default.
- W2040217986 hasConcept C45189115 @default.
- W2040217986 hasConcept C71924100 @default.
- W2040217986 hasConceptScore W2040217986C121608353 @default.
- W2040217986 hasConceptScore W2040217986C126322002 @default.
- W2040217986 hasConceptScore W2040217986C142724271 @default.
- W2040217986 hasConceptScore W2040217986C143998085 @default.
- W2040217986 hasConceptScore W2040217986C159654299 @default.
- W2040217986 hasConceptScore W2040217986C203014093 @default.
- W2040217986 hasConceptScore W2040217986C2778220009 @default.
- W2040217986 hasConceptScore W2040217986C2778580637 @default.
- W2040217986 hasConceptScore W2040217986C2779134260 @default.
- W2040217986 hasConceptScore W2040217986C45189115 @default.
- W2040217986 hasConceptScore W2040217986C71924100 @default.
- W2040217986 hasIssue "1" @default.
- W2040217986 hasLocation W20402179861 @default.
- W2040217986 hasLocation W20402179862 @default.
- W2040217986 hasOpenAccess W2040217986 @default.
- W2040217986 hasPrimaryLocation W20402179861 @default.
- W2040217986 hasRelatedWork W1998885523 @default.
- W2040217986 hasRelatedWork W2040217986 @default.
- W2040217986 hasRelatedWork W2081064592 @default.